Skip to main content
endocrinologyClinical Question·Updated Jul 4, 2026·v1

management of diabetic ketoacidosis [Grok-4.3]

The provided guidelines contain no recommendations for management of diabetic ketoacidosis. [1] [2] The ISPD guideline sets a target overall peritonitis rate of no more than 0.40 episodes per year at risk. [1] The ASPEN consensus defines refeeding syndrome by decreases in serum phosphorus, potassium,

Moderate Evidence14 references·494 words·2 min read·v1
The provided guidelines contain no recommendations for management of diabetic ketoacidosis. [1] [2] The ISPD guideline sets a target overall peritonitis rate of no more than 0.40 episodes per year at risk.

Board Review — High Yield

  • No recommendations or effect sizes for diabetic ketoacidosis management appear in the provided references
  • Provided abstracts contain no data on diabetic ketoacidosis treatment history or landmark trials
  • No data on diabetic ketoacidosis management or related effect sizes appear in any provided reference.
  • No provided reference examines diabetic ketoacidosis or its management
  • No references address diabetic ketoacidosis management or emerging therapies.

Deep Dive — Evidence Details

References

  1. [1]

    Li PK, Chow KM, Cho Y et al.. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2022). PMID: 35264029

    L2GUIDELINECited in: Bottom Line
  2. [2]

    da Silva JSV, Seres DS, Sabino K et al.. ASPEN Consensus Recommendations for Refeeding Syndrome. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition (2020). PMID: 32115791

    L5REVIEW_NARRATIVECited in: Bottom Line
  3. [3]

    Sejersen T, Kroksmark AK, Törnblom A et al.. Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register data. Journal of neuromuscular diseases (2026). PMID: 42400353

    L3COHORTCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  4. [4]

    Hashimoto Y, Yoshida M, Miyagi T et al.. Association between GLIM-defined malnutrition and in-hospital costs in adults with sepsis: A sub analysis of a prospective cohort study. JPEN. Journal of parenteral and enteral nutrition (2026). PMID: 42400337

    L3COHORTCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  5. [5]

    Pancini E, Cremaschi G, Degani M et al.. Savor-Aging: The Art of Savoring Positive Emotions in Older Adulthood-A Randomized Controlled Trial. Applied psychology. Health and well-being (2026). PMID: 42400304

    L1RCTCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  6. [6]

    Sakai A, Sugiyama M, Onodera M et al.. Adeno-Associated Virus Gene Therapy for Spinal Muscular Atrophy Induces Hepatotoxicity via Cytokine and Macrophage Activation. Liver international : official journal of the International Association for the Study of the Liver (2026). PMID: 42400303

    L4CASE_REPORTCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  7. [7]

    Li Y, Wen J, Cao X et al.. Small Extracellular Vesicle-TLN1 Modulates Gastric Cancer Cells and Remodels Lymphatic Endothelial Cells Through AKT Activation to Potentiate Lymphatic Metastasis. Cell biology international (2026). PMID: 42400362

    L5OTHERCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  8. [8]

    Pasanen N, Talala K, Remmers S et al.. Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC). BJU international (2026). PMID: 42400346

    L5OTHERCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  9. [9]

    Pastukh V, Zhang J, Alexander PG et al.. Repurposing Metformin to Promote Fracture Callus Maturation via AMPK-Driven Metabolic Activation. Journal of orthopaedic research : official publication of the Orthopaedic Research Society (2026). PMID: 42400344

    L5OTHERCited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  10. [10]

    Ichimasa K, Kudo SE, Kouyama Y et al.. Competing Mortality Redefines the Net Benefit of Additional Surgery After Endoscopic Resection for T1 Colorectal Cancer in Older Adults. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society (2026). PMID: 42400343

    L5REVIEW_NARRATIVECited in: Bottom Line, Background: Evolution of Treatment, Current Evidence and Standard, Applicability and Caveats, On the Horizon
  11. [11]

    Spano L, Bourdon C, Lajnef M et al.. Epigenetic Age Accelerations and the Clinical Presentation of Bipolar Disorders: A Latent Profile Analysis in the FACE-BD Sample. Bipolar disorders (2026). PMID: 42400340

    L5OTHERCited in: Bottom Line, Current Evidence and Standard, Applicability and Caveats
  12. [12]

    Tarasov G, Cohen R, Warshawski S et al.. Couples' optimism, stress, and quality of life when undergoing fertility treatments: A cross-sectional study with prospective outcome assessment. Women's health (London, England) (2026). PMID: 42400338

    L5OTHERCited in: Bottom Line, Current Evidence and Standard, Applicability and Caveats
  13. [13]

    Knaak S, Reichert OS, Ameyaw S et al.. Supporting Physician Well-being and Mental Health Clinical Skill Development: Evaluation of Mental Health Skills Groups for Physicians. Healthcare management forum (2026). PMID: 42400336

    L5OTHERCited in: Current Evidence and Standard
  14. [14]

    Ge H, Fang F, Wan R et al.. Genome-Wide Identification and Functional Characterization of Dof Transcription Factors Involved in Salt Stress Responses in Taraxacum kok-saghyz. Physiologia plantarum (2026). PMID: 42400331

    L5OTHERCited in: Current Evidence and Standard

Revision History

All updates applied to this page

Loading revisions…